News

This November marks 20 years of science, discovery, innovation, collaboration and education at the BC Cancer Genome Sciences (GSC).To celebrate, 16 GSC researchers, partners, former trainees and leaders in the field of genomics will give presentations at a celebratory scientific symposium.

A new B.C.-led national clinical trial is considered a major advancement in precision medicine for prostate cancer, and is the first of its kind in the world.

B.C. ranks among the best in the world for cancer outcomes and is a leader in cancer research and precision medicine.

The research director of the Centre for Lymphoid Cancer at BC Cancer is the first Canadian recipient.

Donation from the Collings Stevens Family Foundation to BC Cancer Foundation supports critical cancer research.